DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes
News | 01. 05. 2016
Afferent Pharmaceuticals
Afferent Pharmaceuticals named one of "The Hottest Startups of 2015" by Forbes.
